Effect of a 6-month intervention with cooking oils containing a high concentration of monounsaturated fatty acids (olive and canola oils) compared with control oil in male asian indians with nonalcoholic fatty liver disease

Diabetes Technology and Therapeutics

Volumn 16, Issue 4, 2014, Pages 255-261

  Nigam, Priyanka ^a,b,c,d   Bhatt, Suryaprakash ^e   Misra, Anoop ^a,b,f   Chadha, Davinder S ^g   Vaidya, Meera ^c   Dasgupta, Jharna ^a   Pasha, Qadar M A ^h  

^a National Diabetes Obesity and Cholesterol Foundation   (India)

^b Diabetes Foundation India New Delhi   (India)

^c Govt MH College of Home Science and Science for Women   (India)

^d Lavandoo Health India ^*  (India)

^e ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

^f Fortis CDOC Center of Excellence for Diabetes   (India)

^g ARMED FORCES MEDICAL COLLEGE   (India)

^h CSIR INSTITUTE OF GENOMICS AND INTEGRATIVE BIOLOGY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

CANOLA OIL; GLUCOSE; INSULIN; LIPID; LIPOPROTEIN; MONOUNSATURATED FATTY ACID; OLIVE OIL; POLYUNSATURATED FATTY ACID; SAFFLOWER OIL; SATURATED FATTY ACID; TRIACYLGLYCEROL; BIOLOGICAL MARKER; FAT INTAKE; VEGETABLE OIL;

ADULT; ANTHROPOMETRY; ARTICLE; ASIAN; BODY MASS; BODY WEIGHT; CLINICAL ASSESSMENT TOOL; CONTROL GROUP; CONTROLLED STUDY; COOKING; COUNSELING; DIETARY INTAKE; FATTY LIVER; GLUCOSE BLOOD LEVEL; HUMAN; INDIAN; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; INTERVENTION STUDY; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONALCOHOLIC FATTY LIVER; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SOYBEAN; TRIACYLGLYCEROL BLOOD LEVEL; ADMINISTRATION AND DOSAGE; BLOOD; CARDIOVASCULAR DISEASES; COMPARATIVE STUDY; DIABETES MELLITUS, TYPE 2; DIET THERAPY; DIRECTIVE COUNSELING; ETHNOLOGY; FAT INTAKE; INDIA; NON-ALCOHOLIC FATTY LIVER DISEASE; PATHOPHYSIOLOGY; RISK REDUCTION; TREATMENT OUTCOME;

ADULT; BIOLOGICAL MARKERS; BODY MASS INDEX; CARDIOVASCULAR DISEASES; COOKING; DIABETES MELLITUS, TYPE 2; DIETARY FATS; DIRECTIVE COUNSELING; FATTY ACIDS, MONOUNSATURATED; HUMANS; INDIA; INSULIN RESISTANCE; LIPIDS; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; PLANT OILS; RISK REDUCTION BEHAVIOR; SAFFLOWER OIL; TREATMENT OUTCOME;

EID: 84896324230     PISSN: 15209156     EISSN: 15578593     Source Type: Journal    
DOI: 10.1089/dia.2013.0178     Document Type: Article

References (28)

1. Mohan V, Farooq S, Deepa M, Ravikumar R, Pitchumoni CS: Prevalence of non-alcoholic fatty liver disease in urban south Indians in relation to different grades of glucose intolerance and metabolic syndrome. Diabetes Res Clin Pract 2009;84:84-91.
2. Meigs JB: Invited commentary: insulin resistance syndrome? Syndrome X? Multiple metabolic syndrome? A syndrome at all? Factor analysis reveals patterns in the fabric of correlated metabolic risk factors. Am J Epidemiol 2000;152:908-911; discussion 912.
3. Fabbrini E, Magkos F, Mohammed BS, Pietka T, Abumrad NA, Patterson BW, Okunade A, Klein S: Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity. Proc Natl Acad Sci USA 2009;106:15430-15435.
4. Marchesini G, Bugianesi E, Forlani G, Cerrelli F, Lenzi M, Manini R, Natale S, Vanni E, Villanova N, Melchionda N, Rizzetto M: Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology 2003;37:917-923. (Pubitemid 36397405)
5. Misra A: Insulin resistance syndrome: current perspective and its relevance in Indians. Indian Heart J 1998;50: 385-395.
6. Wasir JS, Misra A: The metabolic syndrome in Asian Indians: impact of nutritional and socio-economic transition in India. Metab Syndr Relat Disord 2004;2:14-23. (Pubitemid 39341704)
7. Misra A, Khurana L: Obesity and the metabolic syndrome in developing countries. J Clin Endocrinol Metab 2008;93(11 Suppl 1):S9-S30.
8. Mohan V, Deepa R, Rani SS, Premalatha G; Chennai Urban Population Study (CUPS No.5): Prevalence of coronary artery disease and its relationship to lipids in a selected population in South India: the Chennai Urban Population Study (CUPS No. 5). J Am Coll Cardiol 2001;38:682-687. (Pubitemid 32835736)
9. Misra A, Misra R, Wijesuriya M, Banerjee D: The metabolic syndrome in South Asians: continuing escalation & possible solutions. Indian J Med Res 2007;125:345-354. (Pubitemid 46805451)
10. Bajaj S, Nigam P, Luthra A, Pandey RM, Kondal D, Bhatt SP, Wasir JS, Misra A: A case-control study on insulin resistance, metabolic co-variates & prediction score in non-alcoholic fatty liver disease. Indian J Med Res 2009;129:285-292.
11. Amarapurkar DN, Amarapurkar AD: Nonalcoholic steato-hepatitis: clinicopathological profile. J Assoc Physicians India 2000;48:311-313.
12. Li Z, Soloski MJ, Diehl AM: Dietary factors alter hepatic innate immune system in mice with nonalcoholic fatty liver disease. Hepatology 2005;42:880-885. (Pubitemid 41401126)
13. Hussein O, Grosovski M, Lasri E, Svalb S, Ravid U, Assy N: Monounsaturated fat decreases hepatic lipid content in nonalcoholic fatty liver disease in rats. World J Gastroenterol 200;13:361-368.
14. Thimmayamma BVS, Rau P: Diet survey methods. In: Thimmayamma BVS, ed. A Handbook of Schedule and Guidelines in Socio-Economic and Diet Survey. New Delhi: National Institute of Nutrition, Indian Council of Medical Research, 1987:1-8.
15. Caumo APG, Brunani A, Luzi L: New insights on the simultaneous assessment of insulin sensitivity and beta cell function with the HOMA2 method. Diabetes Care 2006; 29:2733-2734. (Pubitemid 44912210)
16. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifing JL, Ward WK, Beard JC, Palmer JP: Quantification of the relationship between insulin sensitivity and beta-cell function in human subjects. Evidence for a hyperbolic function. Diabetes 1993;42:1663-1672. (Pubitemid 23318125)
17. Hsiao PJ, Yang YH, Lin WY, Yang JF, Chiu CC, Chuang WL, Tsai TR, Yu ML: Significant correlations between severe fatty liver and risk factors for metabolic syndrome. J Gas-troenterol Hepatol 2007;22:2118-2123.
18. Saadeh S, Younossi ZM, Remer EM, Gramlich T, Ong JP, Hurley M, Mullen KD, Cooper JN, Sheridan MJ: The utility of radiological imaging in nonalcoholic fatty liver disease. Gastroenterology 2002;123:745-750. (Pubitemid 34977081)
19. Hamer OW, Aguirre DA, Casola G, Lavine JE, Woenckhaus M, Sirlin CB: Fatty liver: imaging patterns and pitfalls. Radiographics 2006;26:1637-1653.
20. Folsom AR, Ma J, McGovern PG, Eckfeldt H: Relation between plasma phospholipid saturated fatty acids and hyperinsulinemia. Metabolism 1996;45:223-228. (Pubitemid 26102621)
21. Assy N, Nassar F, Nasser G, Grosovski M: Olive oil consumption and non-alcoholic fatty liver disease. World J Gastroenterol 2009;15:1809-1815.
22. Garg A: High-monounsaturated-fat diets for patients with diabetes mellitus: a meta-analysis. Am J Clin Nutr 1998;67: 577S-582S. (Pubitemid 28117244)
23. Spadaro L, Magliocco O, Spampinato D, Piro S, Oliveri C, Alagona C, Papa G, Rabuazzo AM, Purrello F: Effects of n-3 polyunsaturated fatty acids in subjects with nonalcoholic fatty liver disease. Dig Liver Dis 2008;40: 194-199. (Pubitemid 351181793)
24. Capanni M, Calella F, Biagini MR, Genise S, Raimondi L, Bedogni G, Svegliati-Baroni G, Sofi F, Milani S, Abbate R, Surrenti C, Casini A: Prolonged n-3 polyunsaturated fatty acid supplementation ameliorates hepatic steatosis in patients with non-alcoholic fatty liver disease: a pilot study. Aliment Pharmacol Ther 2006;23:1143-1151. (Pubitemid 43779354)
25. Sofi F, Giangrandi I, Cesari F, Corsani I, Abbate R, Gensini GF, Casini A: Effects of a 1-year dietary intervention with n-3 polyunsaturated fatty acid-enriched olive oil on nonalcoholic fatty liver disease patients: a preliminary study. Int J Food Sci Nutr 2010;61:792-802.
26. Soriguer F, Morcillo S, Cardona F, Rojo-Martínez G, de la Cruz Almaráz M, Ruiz de Adana Mde L, Olveira G, Tina-hones F, Esteva I: Pro12Ala polymorphism of the PPARG2 gene is associated with type 2 diabetes mellitus and peripheral insulin sensitivity in a population with a high intake of oleic acid. J Nutr 2006;136:2325-2330. (Pubitemid 44329990)
27. Clarke SD: Nonalcoholic steatosis and steatohepatitis. I. Molecular mechanism for polyunsaturated fatty acid regulation of gene transcription. Am J Physiol Gastrointest Liver Physiol 2001;281:G865-G869.
28. Mathiesen U L, Franzen L E, Aselius H, Resjö M, Jacobsson L, Foberg U, Frydén A, Bodemar G: Increased liver echo-genicity at ultrasound examination reflects degree of stea-tosis but not of fibrosis in asymptomatic patients with mild/moderate abnormalities of liver transaminases. Dig Liver Dis 2002;34:516-522. (Pubitemid 34830694)